Man Group
RYTM icon

Man Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Man Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.64M Buy
50,788
+46,766
+1,163% +$4.23M 0.01% 1076
2026
Q1 		$350K Sell
4,022
-5,536
-58% -$538K ﹤0.01% 2179
2025
Q4 		$1.02M Sell
9,558
-119,772
-93% -$12.7M ﹤0.01% 1668
2025
Q3 		$13.1M Buy
+129,330
New +$12M 0.02% 681
2023
Q3 		– Hold
0
– – – 1693
2018
Q4 		– Sell
-56,360
Closed -$1.64M – 2088
2018
Q3 		$1.64M Buy
+56,360
New +$1.78M 0.01% 1490

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Man Group's RYTM Position: Q2 2026 in Review

Man Group increased its Rhythm Pharmaceuticals (RYTM) stake by 1,163% in Q2 2026, buying an estimated $4.23M and bringing the position to 50,788 shares worth $5.64M. The position accounts for 0.01% of the portfolio, ranked #1076.

Man Group first reported a position in RYTM in Q3 2018 and has held it in 5 quarters since. The position peaked at $13.1M in Q3 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Man Group held 50,788 shares of Rhythm Pharmaceuticals worth $5.64M as of Q2 2026.
  • Man Group bought 46,766 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.23M.
  • Rhythm Pharmaceuticals made up 0.01% of Man Group's portfolio in Q2 2026, its #1076 holding.
  • Man Group first reported a position in Rhythm Pharmaceuticals in Q3 2018 and has held it in 5 quarters since.
  • Man Group's Rhythm Pharmaceuticals position peaked at $13.1M in Q3 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.